Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

231.17
+0.46970.20%
Post-market: 231.350.1766+0.08%19:30 EDT
Volume:3K
Turnover:791.94K
Market Cap:463.85M
PE:- -
High:231.68
Open:231.68
Low:231.17
Close:230.70
52wk High:244.35
52wk Low:160.91
Shares:2.01M
Float Shares:2.01M
Volume Ratio:0.42
T/O Rate:0.17%
Dividend:0.95
Dividend Rate:0.41%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 12

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Sep 12

Regeneron and Sanofi Complete Key Dupilumab Itch Study, Expanding Dermatology Upside

TIPRANKS
·
Sep 12

Political and General News Events from September 11

Reuters
·
Sep 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Sep 11

Revolution Medicines Director Lorence H. Kim Disposes of 17,090 Common Shares Worth USD 3.57 Million

Reuters
·
Sep 11

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Champions Oncology Q1 Revenue Rises on Research Services Business

Reuters
·
Sep 11

Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.

Dow Jones
·
Sep 11

Amgen’s New Repatha Plaque Trial: What Investors Should Watch

TIPRANKS
·
Sep 11

Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says

MT Newswires Live
·
Sep 10

Dow's 300-Point Drop Led by Losses in Shares of Nvidia Corp., Amgen

Dow Jones
·
Sep 10

Revolution Medicines to Gain From Drug Expansion, New Combination Therapies, Morgan Stanley Says

MT Newswires Live
·
Sep 10

Revolution Medicines, Inc. : Morgan Stanley Initiates Coverage with Overweight Rating; Price Target $255

THOMSON REUTERS
·
Sep 10

BeOne Medicines FY26 H1 Net Income Climbs to Us$464.36 Million; Revenue Rises 32.3% to Us$3.22 Billion

Reuters
·
Sep 10

Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong

Dow Jones
·
Sep 10

Amgen to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 10

Sweden's Biovica Q1 Sales Rise on Pharma Services Growth

Reuters
·
Sep 09

Sanofi, Regeneron Could Extend Dupixent Patent

Dow Jones
·
Sep 09

Regeneron Pharmaceuticals, Inc. : Bmo Raises Target Price to $920 from $800

THOMSON REUTERS
·
Sep 09